会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 95. 发明授权
    • Zinc binding compounds and their method of use
    • 锌结合化合物及其使用方法
    • US08445702B2
    • 2013-05-21
    • US13030743
    • 2011-02-18
    • Kyle Gee
    • Kyle Gee
    • C07D311/88G01N33/20
    • C07D311/82C08B37/0039G01N31/22G01N33/5308G01N33/6872
    • The present invention provides a metal chelator and methods that facilitate binding, detecting, monitoring and quantitating of zinc ions in a sample. The metal chelating moiety of the zinc-binding compound is an analog of the well-known calcium chelator, BAPTA (1,2-bis(2-aminophenoxy)ethane-N,N,N′,N′-tetraacetic acid), wherein the chelating moiety has been modified from a tetraacetic acid moiety to a tri- di- or monoacetic moiety. This change in acetic acid groups on the metal chelating moiety results in the selective bindings of zinc ions in the presence of calcium ions, both of which are present in biological fluids and intracellular cytosolic fluid and organelles.
    • 本发明提供金属螯合剂和促进样品中锌离子结合,检测,监测和定量的方法。 锌结合化合物的金属螯合部分是众所周知的钙螯合剂BAPTA(1,2-双(2-氨基苯氧基)乙烷-N,N,N',N'-四乙酸)的类似物,其中 螯合部分已从四乙酸部分修饰为三 - 或一乙酸部分。 金属螯合部分上乙酸基团的这种变化导致锌离子在钙离子存在下的选择性结合,两者都存在于生物流体和细胞内胞质溶液和细胞器中。